Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00429507 · ClinicalTrials.gov registry record · Phase 2
Sm-EDTMP and Autologous Peripheral Blood Stem Cell Transplantation for Breast Cancer Patients With Bone Only Metastases
A Phase 2 study, sponsored by M.D. Anderson Cancer Center.
- Completed
- Registry status
- Phase 2
- Development phase
- 12
- Enrollment target
NCT00429507: Completed Phase 2 study, sponsored by M.D. Anderson Cancer Center.
NCT00429507 is a Phase 2 study that has completed, run by M.D. Anderson Cancer Center. The registered enrollment target is 12 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00429507, a Phase 2 study, has completed, sponsored by M.D. Anderson Cancer Center.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 12 participants
- Enrollment target
Study Summary
Primary objectives: \- To determine the time to progression in subjects with breast cancer metastatic to bone only treated with 153Sm-EDTMP and Autologous Peripheral Blood Stem Cell Transplantation (PBSCT). Secondary objectives: * To determine the overall survival at one year. * To determine the efficacy of 153Sm-EDTMP at 6 months. * To assess pain in subjects treated with 153Sm-EDTMP. * To determine the safety of 153Sm-EDTMP.
Interventions
- BEHAVIORAL Questionnaire
- PROCEDURE Stem Cell Transplant
- DRUG 153 Sm-EDTMP
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 12 participants |
| Start Date | 2007-03 |
| Est. Completion | 2014-11 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00429507
The ClinicalTrials.gov registry entry for NCT00429507 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 12 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is M.D. Anderson Cancer Center, which has 2,692 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Questionnaire is the first listed.
NCT00429507 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00429507 about?
NCT00429507 is a clinical study titled "Sm-EDTMP and Autologous Peripheral Blood Stem Cell Transplantation for Breast Cancer Patients With Bone Only Metastases". Primary objectives: \- To determine the time to progression in subjects with breast cancer metastatic to bone only treated with 153Sm-EDTMP and Autologous Peripheral Blood Stem Cell Transplantation (PBSCT). Secondary objectives: * To determine the overall survival at one year. * To determine the ...
What is the current status of trial NCT00429507?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 12 participants. The study started on 2007-03. Estimated completion is 2014-11.
What interventions are being tested in trial NCT00429507?
The interventions under investigation include: Questionnaire (BEHAVIORAL), Stem Cell Transplant (PROCEDURE), 153 Sm-EDTMP (DRUG).
Who is sponsoring clinical trial NCT00429507?
This trial is sponsored by M.D. Anderson Cancer Center, which has 2,692 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.